In summary, our study suggests that antidiabetic DPP-4i as a potential orchestrator reprograms tumor microenvironment that facilitates murine BC metastasis by interacting with BC cells via a ROS–NRF2–HO-1–NF-κB–NLRP3 axis. The gene discussed is NLRP3; the disease is breast cancer.